5/5/2025 - 9:56 AM EST - Microbix Biosystems Inc. : And commercialization partner, Sequel Pharma, LLC, has executed an agreement with a leading international contract development and manufacturing organization for production of the formulated and packaged drug of Kinlytic® urokinase, a biologic drug for dissolving blood clots. Microbix Biosystems Inc.
shares T.MBX are trading unchanged at $0.39.
